Jensen Quality Growth J (JENSX)
55.75
-0.29 (-0.52%)
USD |
Jun 27 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.82% | 9.603B | 0.76% | 12.33% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -661.39M | -2.21% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks long-term capital appreciation. To achieve its objective, the fund invests in equity securities of approximately 25 to 30 companies. Equity securities in which the fund invests as a principal strategy consist primarily of publicly traded common stocks of U.S. companies. It may purchase securities when they are priced below their intrinsic values as determined by the Adviser. The fund may sell all or part of its position in a company when the Adviser has determined that another qualifying security has a greater opportunity to achieve the fund's objective. It is non-diversified. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | JENSX |
| Equity Style | Large Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Blend |
| Category Index | Russell 1000 TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Jensen |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Eric Schoenstein | 18.43 yrs |
| Robert McIver | 17.22 yrs |
| Kurt Havnaer | 14.68 yrs |
| Allen Bond | 11.09 yrs |
| Kevin Walkush | 11.09 yrs |
| Adam Calamar | 8.67 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
90
-661.39M
-21.14B
Category Low
39.68B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of May 31, 2022
Performance Versus Category
As of June 27, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of June 27, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| PepsiCo Inc | 6.81% | 164.02 | -1.40% |
| Microsoft Corp | 6.26% | 256.54 | -3.15% |
| Alphabet Inc Class A | 6.06% | 2240.74 | -3.28% |
| Johnson & Johnson | 5.52% | 176.91 | -2.86% |
| Apple Inc | 4.88% | 137.58 | -2.88% |
| UnitedHealth Group Inc | 4.73% | 508.52 | 0.57% |
| Stryker Corp | 4.59% | 197.91 | -2.57% |
| Pfizer Inc | 4.29% | 50.67 | -2.33% |
| Becton, Dickinson and Co | 4.28% | 244.51 | -2.24% |
| Accenture PLC Class A | 4.18% | 283.90 | -2.98% |
Basic Info
| Investment Strategy | |
| The investment seeks long-term capital appreciation. To achieve its objective, the fund invests in equity securities of approximately 25 to 30 companies. Equity securities in which the fund invests as a principal strategy consist primarily of publicly traded common stocks of U.S. companies. It may purchase securities when they are priced below their intrinsic values as determined by the Adviser. The fund may sell all or part of its position in a company when the Adviser has determined that another qualifying security has a greater opportunity to achieve the fund's objective. It is non-diversified. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | JENSX |
| Equity Style | Large Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Blend |
| Category Index | Russell 1000 TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Jensen |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Eric Schoenstein | 18.43 yrs |
| Robert McIver | 17.22 yrs |
| Kurt Havnaer | 14.68 yrs |
| Allen Bond | 11.09 yrs |
| Kevin Walkush | 11.09 yrs |
| Adam Calamar | 8.67 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (6-27-22) | 0.76% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 24.42 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of May 31, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 8/3/1992 |
| Last Annual Report Date | 5/31/2021 |
| Last Prospectus Date | 9/30/2021 |
| Share Classes | |
| JENIX | Inst |
| JENRX | Retirement |
| JENYX | Inst |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |